M.D. ANDERSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Evaluation of the Signa Excite 3.0 T MRI Excite for Detection and Characterization of Liver Lesions

Completed

Conditions: Liver Cancer

Interventions: Procedure: Signa Excite 3.0 T MRI Scan

First Posted Date: 2007-09-11

Last Posted Date: 2012-07-31

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 16

Registration Number: NCT00527891

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Lymphoscintigraphy in Patients With Vaginal Cancer

Not Applicable

Completed

Conditions: Vaginal Cancer

Interventions: Procedure: Lymphoscintigraphy

First Posted Date: 2007-09-11

Last Posted Date: 2012-08-01

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 14

Registration Number: NCT00528034

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Evaluation of the Bio-Seal Biopsy Track Plug

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Other: No lung plug
Device: Bio-Seal Track Plug

First Posted Date: 2007-09-11

Last Posted Date: 2012-08-07

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 77

Registration Number: NCT00527722

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients

Phase 1

Completed

Conditions: Melanoma
Brain Neoplasms

Interventions: Drug: Lomustine
Drug: Temozolomide
Drug: Thalidomide

First Posted Date: 2007-09-11

Last Posted Date: 2018-11-14

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 17

Registration Number: NCT00527657

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Pancreatic Cancer Genetic Epidemiology (PACGENE) Study

Active, not recruiting

Conditions: Pancreatic Cancer

Interventions: Behavioral: Questionnaire

First Posted Date: 2007-09-10

Last Posted Date: 2020-01-06

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 4770

Registration Number: NCT00526578

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy

Phase 4

Completed

Conditions: Esophageal Diseases
Gastrointestinal Diseases
Disorder of the Genitourinary System
Gynecologic Diseases
Kidney Diseases
Liver Diseases
Pancreatic Diseases
Prostate Cancer
Spinal Disease

Interventions: Device: Vigileo Monitor
Device: FloTrac Sensor

First Posted Date: 2007-09-10

Last Posted Date: 2012-01-16

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 49

Registration Number: NCT00526331

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Cancer Genetics CD-ROM for Hispanics

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Behavioral: Focus Group
Behavioral: Computer Program
Other: Written Materials
Behavioral: Questionnaires

First Posted Date: 2007-09-06

Last Posted Date: 2013-04-10

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 37

Registration Number: NCT00525980

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸
The Cancer and Chronic Disease Consortium (CCDC) of El Paso, El Paso, Texas, United States

CFAR Study in Patients With Chronic Lymphocytic Leukemia

Phase 2

Completed

Conditions: Chronic Lymphocytic Leukemia
Leukemia

Interventions: Drug: Cyclophosphamide
Drug: Fludarabine
Drug: Alemtuzumab
Drug: Rituximab

First Posted Date: 2007-09-06

Last Posted Date: 2013-03-04

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 60

Registration Number: NCT00525603

Locations: 🇺🇸
The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States

Melanoma Detection by Oblique-Incidence Optical Spectroscopy

Completed

Conditions: Skin Cancer

Interventions: Procedure: OIR Imaging

First Posted Date: 2007-09-06

Last Posted Date: 2012-01-31

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 490

Registration Number: NCT00526032

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Brachytherapy for Prostatic Carcinoma Patients

Phase 2

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Drug: Brachytherapy
Behavioral: Questionnaire

First Posted Date: 2007-09-06

Last Posted Date: 2024-03-19

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 300

Registration Number: NCT00525720

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy